Trial
NCT04707625
Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment
Phase IVTERMINATEDSAFETYConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
—
Condition
Retinal Vein Occlusion
Intervention
Aflibercept Ophthalmic
Why stopped
IRB stopped study due to safety concerns. No further data collection and what has been collected is not appropriate for analysis.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-24